keyword
https://read.qxmd.com/read/38149157/comparison-of-the-efficacy-and-safety-of-sublingual-versus-oral-misoprostol-for-the-induction-of-labor-a-randomized-open-label-study
#21
JOURNAL ARTICLE
Mamta R Datta, Mousumi D Ghosh, Zainab AyazAhmed Kharodiya
Introduction Misoprostol (prostaglandin E1 analog) is being used for the induction of labor by vaginal, oral, and sublingual routes. Oral misoprostol is the preferred route for induction of labor, but the use of sublingual misoprostol appears promising due to a faster onset of action. This study was done to compare the efficacy and safety of oral and sublingual misoprostol for induction of labor in term pregnancy. Materials and methods One hundred and sixty patients were randomly allocated to one of the two groups to receive 50 micrograms of oral and sublingual misoprostol four hourly for a maximum of six doses...
November 2023: Curēus
https://read.qxmd.com/read/38143963/safety-and-efficacy-of-cervical-ripening-and-induction-of-labor-using-prostaglandin-e1-in-primiparas-multiparas-and-grand-multiparas
#22
JOURNAL ARTICLE
Lior Kashani-Ligumsky, Asaf Bilgory, Ran Neiger
OBJECTIVE: To compare the efficacy and safety of cervical ripening and induction of labor with prostaglandin E1 among primiparas, multiparas and grand multiparas. STUDY DESIGN: This was a retrospective cohort study. RESULTS: Between January and December 2017, 1713 women underwent cervical ripening and induction of labor with prostaglandin E1: 523 were primiparas, 656 were multiparas, and 534 were grand multiparas. Four hundred and seventy-nine (91...
December 2023: Journal of Obstetrics and Gynaecology of India
https://read.qxmd.com/read/38142318/when-do-women-with-second-trimester-pregnancy-loss-need-repeated-doses-of-misoprostol-insights-from-a-teaching-hospital
#23
JOURNAL ARTICLE
Nadav Cohen, Bracha Cohen, Debjyoti Karmakar, Ofer Lavie, Ariel Zilberlicht
BACKGROUND: Cases of second trimester pregnancy loss can be treated either pharmacologically or by surgical evacuation. Misoprostol, an E1-prostaglandin analog, is used to facilitate the evacuation of the uterus. OBJECTIVES: To determine the risk factors associated with patients who were treated with five or more repeated doses of misoprostol. METHODS: We conducted a retrospective study of patients treated with vaginal misoprostol at our institution between December 2016 and October 2021 for second trimester pregnancy loss...
December 2023: Israel Medical Association Journal: IMAJ
https://read.qxmd.com/read/38139264/granulocyte-macrophage-colony-stimulating-factor-combined-with-prostaglandin-e1-create-dendritic-cells-of-leukemic-origin-from-aml-patients-whole-blood-and-whole-bone-marrow-that-mediate-antileukemic-processes-after-mixed-lymphocyte-culture
#24
JOURNAL ARTICLE
Marianne Unterfrauner, Hazal Aslan Rejeski, Anne Hartz, Sophia Bohlscheid, Tobias Baudrexler, Xiaojia Feng, Elias Rackl, Lin Li, Andreas Rank, Giuliano Filippini Velázquez, Christoph Schmid, Jörg Schmohl, Peter Bojko, Helga Schmetzer
Although several (chemotherapeutic) protocols to treat acute myeloid leukemia (AML) are available, high rates of relapses in successfully treated patients occur. Strategies to stabilize remissions are greatly needed. The combination of the (clinically approved) immune-modulatory compounds Granulocyte-Macrophage-Colony-Stimulating-Factor (GM-CSF) and Prostaglandine E1 (PGE-1) (Kit-M) converts myeloid blasts into dendritic cells of leukemic origin (DCleu ). After stimulation with DCleu ex vivo, leukemia-specific antileukemic immune cells are activated...
December 13, 2023: International Journal of Molecular Sciences
https://read.qxmd.com/read/38130782/intra-arterial-lipo-prostaglandin-e1-infusion-for-arterial-spasm-in-liver-transplantation-a-case-report
#25
Moonhwan Kim, Hae Won Lee, Chang Jin Yoon, Boram Lee, Yeongsoo Jo, Jai Young Cho, Yoo-Seok Yoon, Jun Suh Lee, Ho-Seong Han
BACKGROUND: Hepatic artery obstruction is a critical consideration in graft outcomes after living donor liver transplantation. We report a case of diffuse arterial vasospasm that developed immediately after anastomosis and was managed with an intra-arterial infusion of lipo-prostaglandin E1 (PGE1). CASE SUMMARY: A 57-year-old male with hepatitis B virus-related liver cirrhosis and hepatocellular carcinoma underwent ABO-incompatible living donor liver transplant...
December 6, 2023: World Journal of Clinical Cases
https://read.qxmd.com/read/38075002/reactions-to-misoprostol-a-case-report
#26
Arsalan Salari, Aseme Pourrajabi, Samaneh Karami, Zahra Hamidi Madani
BACKGROUND: Most of abortions occur before the 13th week of pregnancy. Nowadays, non-surgical approaches for evacuation of uterine have been replaced with surgical ones due to the reduction in bleeding, fewer complications, ease of management, and cost-effectiveness. Misoprostol is a prostaglandin E1 analog that is used for labor induction. It is known as a safe drug with very few side effects. CASE PRESENTATION: A 29-year-old woman with the gestational age of 11 weeks and 6 days with a diagnosis of cystic hygroma introduced herself to the labor ward...
2023: Clinical Medicine Insights. Case Reports
https://read.qxmd.com/read/38060710/multiple-clinical-indications-of-mifepristone-a-systematic-review
#27
REVIEW
Sharon Mathew, Maria S Ticsa, Soniya Qadir, Aida Rezene, Deepesh Khanna
Mifepristone and misoprostol are globally used medications that have become disparaged through the stigmatization of reproductive healthcare. Patients are hindered from receiving prompt treatment in clinical scenarios where misoprostol and mifepristone are the drugs of choice. It is no exaggeration to emphasize that in cases where reproductive healthcare is concerned. The aim of this paper is to discuss the different indications of mifepristone and to delineate where the discrepancy in accessibility arises...
November 2023: Curēus
https://read.qxmd.com/read/38032490/interaction-of-endocannabinoid-system-and-cyclooxygenase-metabolites-with-fatty-acid-amide-hydrolase-and-cyclooxygenase-enzyme-activities-on-contractile-responses-in-rat-vas-deferens-tissue
#28
JOURNAL ARTICLE
Elif Hilal Vural, Gokce Sevim Ozturk Fincan, Yagmur Okcay, Celil Ilker Askin, Merve Gudul Bacanli, Ismail Mert Vural
The endocannabinoid system and prostaglandins are important modulators in the genitourinary system. This study aimed to investigate the possible interactions between the endocannabinoid system and the cyclooxygenase (COX) pathway on rat vas deferens. For this purpose, the concentration responses of the endocannabinoid anandamide, prostaglandin F2α analog latanoprost, and prostaglandin E1 analog misoprostol on the electrical field stimulation (EFS)-induced contractile responses were obtained. The concentration responses to anandamide were obtained again in the presence of nonselective COX inhibitor flurbiprofen and prostaglandin analogs, while the concentration responses of latanoprost and misoprostol were obtained in the presence of cannabinoid receptor antagonists and fatty acid amide hydrolase (FAAH) enzyme inhibitor URB597...
November 30, 2023: Naunyn-Schmiedeberg's Archives of Pharmacology
https://read.qxmd.com/read/37975485/prostaglandin-e1-infusion-in-persistent-pulmonary-hypertension-of-the-newborn
#29
JOURNAL ARTICLE
Stephanie M Tsoi, Hythem Nawaytou, Hassan Almeneisi, Martina Steurer, Yili Zhao, Jeffrey R Fineman, Roberta L Keller
BACKGROUND: Neonates with persistent pulmonary hypertension of the newborn (PPHN) can present with hypoxia and right ventricular dysfunction with resultant inadequate oxygen delivery and end-organ damage. This study describes the use of prostaglandin-E1 (PGE) for ductal patency to preserve right ventricular systolic function and limit afterload in newborns with PPHN. METHODS: This is a retrospective cohort study that follows the hemodynamics, markers of end-organ perfusion, length of therapeutics, and echocardiographic variables of 57 newborns who used prostglandin-E1 in the setting of PPHN...
November 17, 2023: Pediatric Pulmonology
https://read.qxmd.com/read/37973393/erectile-response-profiles-of-men-using-pde5-inhibitors-combined-with-intracavernosal-injections-as-part-of-a-penile-rehabilitation-program-after-radical-prostatectomy
#30
JOURNAL ARTICLE
Thiago P Furtado, Eduardo P Miranda, Serkan Deveci, Lawrence Jenkins, Joseph Narus, Christian Nelson, John P Mulhall
BACKGROUND: Phosphodiesterase type 5 (PDE5) inhibitor labeling states that these agents should not be used in conjunction with other erectogenic medications for fear of priapism occurring. AIM: We explored the risk of priapism and prolonged erections in men in our post-radical prostatectomy (RP) penile injection program who were using regular PDE5 inhibitor and intracavernosal injections (ICIs) as part of their rehabilitation program. METHODS: The study cohort included men on penile injection therapy who (1) were taking tadalafil 5 mg daily or taking sildenafil 25 mg on noninjection days, (2) had an RP, (3) were using their respective PDE5 inhibitor regularly at the time of penile injection training, and (4) complied with the program instructions regarding penile injection use...
December 22, 2023: Journal of Sexual Medicine
https://read.qxmd.com/read/37951067/phospholipase-d1-activity-is-crucial-for-cytosolic-phospholipase-a-2-dependent-prostaglandin-e-2-formation-in-murine-osteoblastic-mc3t3-e1-cells
#31
JOURNAL ARTICLE
Hans Jörg Leis, Werner Windischhofer
In bone, prostaglandin E2 (PGE2 ) is highly osteogenic and formed by osteoblasts, a key modulatory event in the regulation of bone cell activity. MC3T3-E1 cells are widely used as an in vitro model of osteoblast function. It is still not clear which pathways contribute to the release of AA in these cells. In this study we have focussed on the contribution of phospholipase D (PLD) enzymes to osteoblastic PGE2 formation after stimulation with endothelin-1 (ET-1). Using specific inhibitors of PLD1 and PLD2 we could show that PGE2 formation was strictly dependent on PLD1 but not PLD2 activity and cytosolic phospholipase A2 (cPLA2 ) was activated by triggering through PLD1...
October 30, 2023: Prostaglandins, Leukotrienes, and Essential Fatty Acids
https://read.qxmd.com/read/37901635/documented-reperfusion-of-the-retina-on-fluorescein-angiography-after-administration-of-intravenous-prostaglandin-e1-for-central-retinal-artery-occlusion-a-case-report
#32
J Anthony Chacko, Heather V Broyles, Joseph G Chacko, Sami H Uwaydat
Central retinal artery occlusion (CRAO) can result in devastating permanent vision loss. Presently, there is no evidence-based treatment for CRAO that is widely accepted. In the literature, multiple studies propose intravenous (IV) prostaglandin E1 (IV PGE1) as a potential treatment option for patients with CRAO. We illustrate 2 cases of CRAO successfully treated with IV PGE1. In both cases, our patients with vascular risk factors were diagnosed with CRAO of the left eye. They were started on twice daily IV 40 μg PGE1 in 100 mL normal saline, with each dose administered over 3 h...
2023: Case Reports in Ophthalmology
https://read.qxmd.com/read/37876266/use-of-prostaglandin-and-cyclophosphamide-for-pediatric-lupus-with-digital-gangrene-back-to-safety-before-hitting-the-axe
#33
JOURNAL ARTICLE
Hritvik Jain, Aliza Mittal, Siyaram Didel, Prawin Kumar, Kuldeep Singh
Digital gangrene is a rare presenting feature of childhood lupus and only a reported incidence of 1.3%. We describe two cases of pediatric onset systemic lupus erythematosus (SLE), both 16 years old, presenting with digital gangrene and the successful salvage of the digits after using intravenous cyclophosphamide for immunosuppression and use of intravenous prostaglandin E1 infusions for limb reperfusion. Both of the patients responded exceptionally to the infusions with resolution of gangrene and near-total preservation of the functionality of toes...
October 24, 2023: Lupus
https://read.qxmd.com/read/37806440/effect-of-specialized-pro-resolving-lipid-mediators-in-the-regulation-of-vascular-tone-and-inflammation-in-human-saphenous-vein
#34
JOURNAL ARTICLE
Zeynep Celik, Gulsev Ozen, Seynur Sunar, Saygın Türkyılmaz, Gülsüm Türkyılmaz, Ali Aycan Kavala, Önder Teskin, B Sönmez Uydeş Doğan, Gokce Topal
Specialized pro-resolving lipid mediators (SPMs), derived from polyunsaturated fatty acids are important mediators in the resolution of inflammation. Recent studies have focused on the effects of SPMs in cardiovascular health and diseases. However, little is known about the effect SPMs on human vascular tone. Therefore, in this study it is aimed to investigate the effect of various SPMs including resolvin D- and E-series, maresin-1 (MaR1) and lipoxin-A4 (LxA4) on the vascular tone of human isolated saphenous vein (SV) preparations under inflammatory conditions...
October 6, 2023: Prostaglandins & Other Lipid Mediators
https://read.qxmd.com/read/37783065/effects-of-17%C3%AE-estradiol-on-the-uterine-luteolytic-cascade-in-bovine-females-at-the-end-of-diestrus
#35
JOURNAL ARTICLE
Isabella Rio Feltrin, Amanda Guimarães da Silva, Cecília Constantino Rocha, Priscila Assis Ferraz, Paola Maria da Silva Rosa, Thiago Martins, Juliano Coelho da Silveira, Milena Lopes Oliveira, Mario Binelli, Guilherme Pugliesi, Claudia Maria Bertan Membrive
In cattle, 17β-estradiol (E2) is essential for triggering luteolysis via the synthesis of prostaglandin F2α (PGF2α). We aimed to evaluate the effects of E2-treatment on day 15 of the estrous cycle on the transcript abundance of genes involved in the PGF2α synthetic cascade. Nelore heifers (N = 50) were subjected to a hormonal protocol for the synchronization of ovulation. Between days 14 and 23 after estrus, the area (cm2 ) and blood perfusion (%) of the corpus luteum (CL) and progesterone (P4) plasma concentrations were evaluated daily...
September 28, 2023: Theriogenology
https://read.qxmd.com/read/37761532/cumulative-dose-of-prostaglandin-e1-determines-gastrointestinal-adverse-effects-in-term-and-near-term-neonates-awaiting-cardiac-surgery-a-retrospective-cohort-study
#36
JOURNAL ARTICLE
Noa Ofek Shlomai, Gilad Lazarovitz, Benjamin Koplewitz, Smadar Eventov Friedman
OBJECTIVE: This study aimed to assess the association between treatment characteristics of prostaglandin E1 including initiation time and duration, maximal and cumulative doses, and adverse effects. DESIGN: A retrospective cohort study in which medical records of neonates with duct-dependent lesions were studied for treatment parameters and adverse effects. Multivariable logistic regression model was applied for testing the effect PGE1 variables on outcomes. MAIN OUTCOME MEASURES: The primary outcomes of this study were association of adverse effects of PGE1 treatment with maximal dose, cumulative dose, and treatment duration...
September 19, 2023: Children
https://read.qxmd.com/read/37732033/bioactive-lipid-based-therapeutic-approach-to-covid-19-and-other-similar-infections
#37
JOURNAL ARTICLE
Undurti N Das
COVID-19 is caused by SARS-CoV-2 infection. Epithelial and T, NK, and other immunocytes release bioactive lipids especially arachidonic acid (AA) in response to microbial infections to inactivate them and upregulate the immune system. COVID-19 (coronavirus) and other enveloped viruses including severe acute respiratory syndrome (SARS-CoV-1 of 2002-2003) and Middle East respiratory syndrome (MERS; 2012-ongoing) and hepatitis B and C (HBV and HCV) can be inactivated by AA, γ-linolenic acid (GLA, dihomo-GLA (DGLA), eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), which are precursors to several eicosanoids...
2023: Archives of Medical Science: AMS
https://read.qxmd.com/read/37717370/platelets-provide-robustness-of-spatial-blood-coagulation-to-the-variation-of-initial-conditions
#38
JOURNAL ARTICLE
Anna N Balandina, Ekaterina M Koltsova, Alexey M Shibeko, Anna D Kuprash, Valentina A Budkova, Irina A Demina, Anastasiya A Ignatova, Olga A Fadeeva, Ramya Vijay, Sukesh C Nair, Alok Srivastava, Qiang Shi, Fazoil I Ataullakhanov, Mikhail A Panteleev
Activated platelets provide phospholipid surface and secrete coagulation factors, enhancing blood clotting. We investigated the role of platelets in the regulation of blood coagulation spatial dynamics. We activated blood clotting with tissue factor-bearing (TF) surface in platelet-rich plasma (PRP) or platelet-free plasma (PFP). When blood coagulation was initiated by high TF density, clot growth rate (V) in PRP (2 × 105 /μL platelets) was only 15 % greater than in PFP. Spatial distribution of thrombin in PRP had a peak-like shape in the area of the fibrin clot edge, while in PFP thrombin was distributed in the shape of descending plateau...
September 13, 2023: Thrombosis Research
https://read.qxmd.com/read/37704124/imbalanced-serum-levels-of-resolvin-e1-rve1-and-leukotriene-b4-ltb4-may-contribute-to-the-pathogenesis-of-atherosclerosis
#39
JOURNAL ARTICLE
Mohsen Molaei, Ramin Lotfi, Reza Heidarymoghadam, Alireza Rezaiemanesh, Ali Gorgin Karaji, Farhad Salari
Persistent and chronic unresolved inflammation exerts a critical role in developing atherosclerosis; however, mechanisms that prevent the resolution of inflammation in atherosclerosis are poorly delineated. This study aims to evaluate the serum levels of inflammatory high-sensitivity C-reactive protein (hsCRP), pro-inflammatory leukotriene B4 (LTB4), besides anti-inflammatory compounds, including eicosapentaenoic acid (EPA) and its derivative resolvin E1 (RvE1) in patients with atherosclerosis. Thirty-four atherosclerosis patients and thirty-two age- and sex-matched healthy individuals were included in this study...
September 11, 2023: Prostaglandins & Other Lipid Mediators
https://read.qxmd.com/read/37656970/active-versus-expectant-management-for-premature-rupture-of-membranes-at-term-a-randomized-controlled-study
#40
JOURNAL ARTICLE
Fredrick I Awkadigwe, Frank O Ezugwu, George U Eleje, Sylvester O Nweze, Boniface U Odugu, Victor O Dinwoke, Ephraim A Olu, Kelvin E Ortuanya, Malachy N Ezenwaeze, Obiechina C Eze, Johnson I Onyekpa, Ifeanyichukwu J Ofor, Osmond O Onah, Chimdalu U Omeje, Andre U Ezike, Perpetua K Enyinna, Divinefavour E Malachy, Chigozie G Okafor
OBJECTIVE: To compare the effects on feto-maternal outcomes of expectant versus active management for premature rupture of membranes (PROM) at term. METHODS: This was a prospective randomized (1:1) controlled study involving 86 pregnant-women who received either expectant management (n = 43) or active management with misoprostol (n = 43) for PROM at term. Primary outcome was route of delivery. Secondary outcomes were: PROM to presentation interval; latency period; PROM to delivery interval; recruitment to delivery interval; labour and delivery complications...
August 2023: Journal of International Medical Research
keyword
keyword
48126
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.